Why AzurRx BioPharma, Usana Health Are Moving Today
CGIX Stock Price Increases Over 240% Pre-Market: Why It Happened
Cancer Genetics Reports First Quarter 2020 Financial Results and Provides Strategic Business Updates | MarketScreener
Cancer Genetics (NASDAQ:CGIX) Share Price Crosses Below Two Hundred Day Moving Average of $4.15
The Daily Biotech Pulse: Mylan Ramps Up Manufacturing Of Potential COVID-19 Drug, Lexicon Stops Study Early, Masimo To Buy German Ventilation Company